A POTENTIAL BIOMARKER FOR GLIOBLASTOMA?

Glioblastoma is a formidable brain malignancy known for its fast growth and resistance to standard treatments. Studies are constantly underway to identify new treatment strategies, and recently, a unique biomarker named LCA168 has emerged as a potential target for glioblastoma treatment. LCA168 is a protein that is overexpressed in GBM cells compa